Vascular Endothelial Growth Factor Expression Levels of Gingiva in Gingivitis and Periodontitis Patients With/without Diabetes Mellitus

Overview

Journal Inflamm Res

Specialties Allergy & Immunology
Pathology

Date 2010 Feb 4

PMID 20127137

Citations 7

Authors

Gonca Cayir Keles

Burcu Ozkan Cetinkaya

Cafer Eroglu

S Burcak Simsek

Hakki Kahraman

Affiliations

Soon will be listed here.

Abstract

Objective And Design: The aim of this study was to determine vascular endothelial growth factor (VEGF) mRNA expression levels in gingival tissues of gingivitis and periodontitis patients with diabetes mellitus and those without. The hypothesis tested is that expression of VEGF, considered the effective cytokine in the relationship between diabetes and periodontal disease, is differentially affected in gingivitis and periodontitis patients with or without diabetes mellitus compared to healthy controls.

Methods: Forty-five subjects were evaluated in five groups; individuals with gingivitis (group 1; n = 10), individuals with periodontitis (group 2; n = 10), individuals with gingivitis + type II diabetes (group 3; n = 10), individuals with periodontitis + type II diabetes (group 4; n = 10), and individuals without periodontal and systemic disease (group 5; n = 5). VEGF mRNA levels in gingival tissues were measured by quantitative real-time PCR using Lightcycler.

Results: Expression of VEGF mRNA was detected in all groups. There was no significant difference in expression levels of VEGF mRNA between groups (P > 0.05).

Conclusions: VEGF expression is probably related to both maintenance of periodontal health and periodontal tissue destruction. It can be concluded that systemic condition in type II diabetes mellitus under good metabolic control does not seem to have additional effects on gingival tissue VEGF mRNA levels in gingivitis and periodontitis patients.

Citing Articles

Gingival Crevicular Fluid Cytokines in Moderate and Deep Sites of Stage III Periodontitis Patients in Different Rates of Clinical Progression.

Romano F, Del Buono W, Bianco L, Arena M, Mariani G, Di Scipio F Biomedicines. 2020; 8(11).

PMID: 33218047 PMC: 7698864. DOI: 10.3390/biomedicines8110515.

Does Diabetes Induce the Vascular Endothelial Growth Factor (VEGF) Expression in Periodontal Tissues? A Systematic Review.

Nardi G, Ferrara E, Converti I, Cesarano F, Scacco S, Grassi R Int J Environ Res Public Health. 2020; 17(8).

PMID: 32316357 PMC: 7215273. DOI: 10.3390/ijerph17082765.

Salivary cytokine levels in early gingival inflammation.

Belstrom D, Damgaard C, Kononen E, Gursoy M, Holmstrup P, Gursoy U J Oral Microbiol. 2017; 9(1):1364101.

PMID: 28839521 PMC: 5560406. DOI: 10.1080/20002297.2017.1364101.

Vascular endothelial growth factor levels in gingival crevicular fluid before and after periodontal therapy.

R P, Sreedhara A, P I, Sarkar I, Kumar C J Clin Diagn Res. 2015; 8(11):ZC75-9.

PMID: 25584323 PMC: 4290334. DOI: 10.7860/JCDR/2014/8450.5163.

Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease.

Barnes V, Kennedy A, Panagakos F, DeVizio W, Trivedi H, Jonsson T PLoS One. 2014; 9(8):e105181.

PMID: 25133529 PMC: 4136819. DOI: 10.1371/journal.pone.0105181.

References

Zheng P, Chen H, Shi S, Jepsen S, Eberhard J . Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population. J Clin Periodontol. 2006; 33(11):797-802. DOI: 10.1111/j.1600-051X.2006.00987.x. View

Prapulla D, Sujatha P, Pradeep A . Gingival crevicular fluid VEGF levels in periodontal health and disease. J Periodontol. 2007; 78(9):1783-7. DOI: 10.1902/jop.2007.070009. View

Hirose M, Ishihara K, Saito A, Nakagawa T, Yamada S, Okuda K . Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue. J Periodontol. 2001; 72(5):590-7. DOI: 10.1902/jop.2001.72.5.590. View

Loe H, SILNESS J . PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand. 1963; 21:533-51. DOI: 10.3109/00016356309011240. View

Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I . Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest. 1998; 101(6):1219-24. PMC: 508675. DOI: 10.1172/JCI1277. View

Grossi S . Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol. 2002; 6(1):138-45. DOI: 10.1902/annals.2001.6.1.138. View

Ferrara N . Vascular endothelial growth factor. Eur J Cancer. 1996; 32A(14):2413-22. DOI: 10.1016/s0959-8049(96)00387-5. View

Tokoro Y, Yamamoto T, Hara K . IL-1 beta mRNA as the predominant inflammatory cytokine transcript: correlation with inflammatory cell infiltration into human gingiva. J Oral Pathol Med. 1996; 25(5):225-31. DOI: 10.1111/j.1600-0714.1996.tb01376.x. View

Tremolada G, Lattanzio R, Mazzolari G, Zerbini G . The therapeutic potential of VEGF inhibition in diabetic microvascular complications. Am J Cardiovasc Drugs. 2007; 7(6):393-8. DOI: 10.2165/00129784-200707060-00002. View

10.

Guneri P, Unlu F, Yesilbek B, Bayraktar F, Kokuludag A, Hekimgil M . Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients. J Periodontol. 2004; 75(1):91-7. DOI: 10.1902/jop.2004.75.1.91. View

11.

Duh E, Aiello L . Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes. 1999; 48(10):1899-906. DOI: 10.2337/diabetes.48.10.1899. View

12.

Waltenberger J . Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001; 49(3):554-60. DOI: 10.1016/s0008-6363(00)00228-5. View

13.

Stove J, Schoniger R, Huch K, Brenner R, Gunther K, Puhl W . Effects of dexamethasone on proteoglycan content and gene expression of IL-1beta-stimulated osteoarthrotic chondrocytes in vitro. Acta Orthop Scand. 2002; 73(5):562-7. DOI: 10.1080/000164702321022857 . View

14.

Aiba T, Akeno N, Kawane T, Okamoto H, Horiuchi N . Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. Eur J Oral Sci. 1996; 104(5-6):562-9. DOI: 10.1111/j.1600-0722.1996.tb00142.x. View

15.

de Pommereau V, Robert J, Brion M . Periodontal status in insulin-dependent diabetic adolescents. J Clin Periodontol. 1992; 19(9 Pt 1):628-32. DOI: 10.1111/j.1600-051x.1992.tb01710.x. View

16.

Lundy F, Shaw C, McKinnell J, Lamey P, Linden G . Calcitonin gene-related peptide in gingival crevicular fluid in periodontal health and disease. J Clin Periodontol. 1999; 26(4):212-6. DOI: 10.1034/j.1600-051x.1999.260403.x. View

17.

Johnson R, Serio F, Dai X . Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol. 1999; 70(8):848-52. DOI: 10.1902/jop.1999.70.8.848. View

18.

Crofford L, Wilder R, Hla T . Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995; 372(1):83-7. DOI: 10.1016/0014-5793(95)00956-a. View

19.

Connolly D . Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem. 1991; 47(3):219-23. DOI: 10.1002/jcb.240470306. View

20.

Boodhwani M, Sodha N, Mieno S, Xu S, Feng J, Ramlawi B . Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007; 116(11 Suppl):I31-7. PMC: 2723770. DOI: 10.1161/CIRCULATIONAHA.106.680157. View